Big Q2 2025 Earnings! Profit Growth | Thyrocare, Navkar, ICICI Lombard, Bank of Maharashtra

Big Q2 2025 Earnings! Profit Growth & Surprises | Thyrocare, Navkar, ICICI Lombard, Bank of Maharashtra

Q2 2025 results are out — and they’ve brought some real surprises!
Here’s a quick breakdown and detailed comparison of Thyrocare Technologies, Navkar Corporation, ICICI Lombard, and Bank of Maharashtra, covering both year-on-year and quarter-on-quarter performance.

📊 Thyrocare Technologies (PE 52.4)
• Sales: ₹217 Cr — up 22% year-on-year, 12% quarter-on-quarter
• Net Profit: ₹47.8 Cr — up 80% year-on-year, 25% quarter-on-quarter
• EPS: ₹9.06 — strong operational leverage

📦 Navkar Corporation
• Sales: ₹162 Cr — up 19% year-on-year, 17% quarter-on-quarter
• Net Profit: ₹4.35 Cr — up 437% year-on-year
• Turnaround story with improving logistics margins

🏦 Bank of Maharashtra (PE 7.0)
• Sales: ₹7,128 Cr — up 18% year-on-year
• Net Profit: ₹1,669 Cr — up 25% year-on-year
• EPS: ₹2.17 — steady growth, strong PSU performance

🛡️ ICICI Lombard (PE 32.9)
• Sales: ₹6,869 Cr — up 12% year-on-year, 7% quarter-on-quarter
• Net Profit: ₹820 Cr — up 18% year-on-year
• EPS: ₹16.47 — consistent compounding from the insurance leader


---

💡 Summary:

Thyrocare and Navkar show the strongest profit growth.

Bank of Maharashtra remains a value play with consistency.

ICICI Lombard continues its stable leadership in the insurance sector.


Which stock do you think can hit the next target this quarter?
Comment below and don’t forget to like, share, and subscribe to Stock Coney for the quickest and sharpest Q2 updates!